Related references
Note: Only part of the references are listed.Identification of Tricyclic Agonists of Sphingosine-1-phosphate Receptor 1 (S1P1) Employing Ligand-Based Drug Design
Hai-Yun Xiao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials
T. G. Murali Dhar et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Tricyclic thiazoles are a new class of angiogenesis inhibitors
Shridhar Bhat et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
The case for induced pluripotent stem cell-derived cardiomyocytes in pharmacological screening
Jaffar M. Khan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Sphingosine-1-Phosphate and Lymphocyte Egress from Lymphoid Organs
Jason G. Cyster et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate
P. Gergely et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Prolonged Exposure to Sphingosine 1-Phosphate Receptor-1 Agonists Exacerbates Vascular Leak, Fibrosis, and Mortality after Lung Injury
Barry S. Shea et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Differential Effects of Sphingosine 1-Phosphate Receptors on Airway and Vascular Barrier Function in the Murine Lung
Saad Sammani et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
Jerold Chun et al.
CLINICAL NEUROPHARMACOLOGY (2010)
Oral fingolimod (FTY720) for relapsing multiple sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Discovery of potent 3,5-diphenyl-1,2,4-oxadiazole sphingosine-1-phosphate-1 (S1P1) receptor agonists with exceptional selectivity against S1P2 and S1P3
Z Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Sphingosine 1-phosphate and its receptors: An autocrine and paracrine network
H Rosen et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes
M Forrest et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Iron-catalyzed cross-coupling reactions.: A scalable synthesis of the immunosuppressive agent FTY720
G Seidel et al.
JOURNAL OF ORGANIC CHEMISTRY (2004)
Iron-catalyzed cross-coupling reactions
A Fürstner et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
2-aminothiazoles:: A new class of agonist allosteric enhancers of A1 adenosine receptors
MD Chordia et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002)
The immune modulator FTY720 targets sphingosine 1-phosphate receptors
V Brinkmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists
S Mandala et al.
SCIENCE (2002)
Share Paper
